Arthritis & Rheumatology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2015-02-13 canzhujia

审稿速度:1.0
经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？

471 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2015-02-07 medcardio

祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？

493 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-11-20 dreamkobe

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。

388 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-08-22 匿名用户

为什么中科院分区总是四区？

472 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-08-01 匿名用户

审稿速度:1.0 | 投稿命中率:25.0
经验分享：从ARTHRITIS AND RHEUMATISM更名而来

347 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-08-01 匿名用户

投稿命中率:50.0
经验分享：从ARTHRITIS AND RHEUMATISM更名而来。

324 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-08-01 匿名用户

从ARTHRITIS AND RHEUMATISM更名而来的。

258 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2014-07-30 bio0709

审稿速度:3.0 | 投稿命中率:25.0
经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。

281 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2013-05-31 匿名用户

1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用

307 0

[GetPortalCommentsPageByObjectIdResponse(id=509850, encodeId=1e26509850cf, content=审稿速度:1.0 经验分享：under review3周，然后一直evaluating recommendation，一周多了。各位此状态多久会有decision？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=471, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ee3156097, createdName=canzhujia, createdTime=Fri Feb 13 16:43:00 CST 2015, time=2015-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509629, encodeId=0bfc5096298b, content=祝贺楼上的，文章被接收都是最开心的事情。除了两次外籍修改外，还有没有其它心得？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=493, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Sat Feb 07 10:29:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507741, encodeId=244550e7413f, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投稿日期2013.08.13.一个月以后给出大修，要求补实验，共2个评审看的很细致，一个要求修改语言和小的细节，另一个要求验证不少东西，半年后重新投稿，2周内编辑直接接收。重要的是文章有新意。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=388, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96ff1328496, createdName=dreamkobe, createdTime=Thu Nov 20 03:20:00 CST 2014, time=2014-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505503, encodeId=a70a50550328, content=为什么中科院分区总是四区？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=472, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 10:06:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504896, encodeId=a52850489619, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504895, encodeId=3de45048955d, content=投稿命中率:50.0 经验分享：从ARTHRITIS AND RHEUMATISM更名而来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=324, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:36:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504892, encodeId=883650489272, content=从ARTHRITIS AND RHEUMATISM更名而来的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=258, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 01 16:06:00 CST 2014, time=2014-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=504713, encodeId=5228504e13c6, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：今年4月份我们的研究文章被A&R在线发表。从投稿开始到最后接收共耗时11个月，期间给了一次大修，一次小修。审稿周期2-3个月。杂志对研究论文的要求较高，拒稿率很高，文章投出后要先经过杂志社的筛选，一般这个层面要淘汰至少50%以上，而后送评审人评阅，最后给出结果，最终接收率在20%左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=bio0709, createdTime=Wed Jul 30 16:35:00 CST 2014, time=2014-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=496041, encodeId=e5e6496041c7, content=1月底投稿，1审2个月，2个评审专家，给9个月的大修期限。我们对问题的回复比较强劲。修会后，1个月同意接受。证实发表（签文件、交稿费、proof等）估计还要1个月。以上流程介绍希望对后来人有用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=307, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 31 18:15:00 CST 2013, time=2013-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=495609, encodeId=46be4956094b, content=投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed May 08 19:58:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

2013-05-08 匿名用户

投稿第二天给文章编号，并分配编辑，第三天状态显示为under review。希望接下来一切顺利，上帝保佑～

315 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务